CIROZ
Ciliated left-right organizer ZP-N domains-containing protein
Also known as: CIROZ_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CIROZ in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
823 residues, UniProt reviewed canonical sequence.
>Q8N9H9|CIROZ
1 MWGSPALAWA VWLACVQPTV FPWSLSFRSD TDKPSSAAEV LTEASSCWTD TVECFSDYMT
61 LWIPRSHVEG LRRWLARTLH LPGTWRSPDH LDSSLAKCGY FLHLASDGDF LFRVQYSACF
121 VQKEKANYRL EIRIFQKGVM GLERSDRYIM KCPMLRSRLG QESVHCGPMF IQVSRPLPLW
181 RDNRQTPWLL SLRGELVASL EDASLMGLYV DMNATTVTVQ SPRQGLLQRW EVLNTSAELL
241 PLWLVSGHHA YSLEAACPPV SFQPESEVLV HIPKQRLGLV KRGSYIEETL SLRFLRVHQS
301 NIFMVTENKD FVVVSIPAAG VLQVQRCQEV GGTPGTQAFY RVDLSLEFAE MAAPVLWTVE
361 SFFQCVGSGT ESPASTAALR TTPSPPSPGP ETPPAGVPPA ASSQVWAAGP AAQEWLSRDL
421 LHRPSDALAK KGLGPFLQTA KPARRGQTSA SILPRVVQAQ RGPQPPPGEA GIPGHPTPPA
481 TLPSEPVEGV QASPWRPRPV LPTHPALTLP VSSDASSPSP PAPRPERPES LLVSGPSVTL
541 TEGLGTVRPE QDPAKSPGSP LLLRGLSSGD VAAPEPIMGE PGQASEEFQP LARPWRATLA
601 AEELVSHRSP GEPQETCSGT EVERPRQTGP GLPREGARGH MDLSSSEPSQ DIEGPGLSIL
661 PARDATFSTP SVRQPDPSAW LSSGPELTGM PRVRLAAPLA VLPMEPLPPE PVRPAALLTP
721 EASSVGGPDQ ARYLESAPGW PVGQEEWGVA HTSSPPSTQT LSLWAPTGVL LPSLVELEYP
781 FQAGRGASLQ QELTEPTLAL SAESHRPPEL QDSVEGLSER PSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIROZ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CIROZ.
Disease | AllUniProt
Conditions CIROZ is implicated in, by any mechanism.
- Heterotaxy, visceral, 14, autosomal (HTX14) MIM:621080
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 19 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Heterotaxy, visceral, 14, autosomal
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CIROZ
- CIROZ, beta domain
- Domain of unknown function (DUF4556), Ig-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIROZ as an antibody target. Whether an autoantibody or antibody against CIROZ could matter depends on whether native CIROZ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIROZ is annotated as secreted, so native CIROZ circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CIROZ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...